Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II. Biomol Biomed [Internet]. 2007 May 20 [cited 2024 Apr. 27];7(2):113-8. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/3063